drug · enzyme
imlifidase
pre_registrationupdated 3mo agoby Hansa Biopharma AB🔗 ChEMBL
community read0 votes
Enzyme drug with a maximum clinical stage of Approval (across all indications), with an approval for kidney transplant and immune system disease and 7 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying imlifidase
- phase2Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
- phase3A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group
- phase3Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
- phase3A Study With Imlifidase in Anti-GBM Disease
- phase1A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
- —Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
- phase2A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
- phase3Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that